Literature DB >> 702272

Enzyme induction following a single dose of amobarbital in dogs.

P A Reilly, T Inaba, D Kadar, L Endrenyi.   

Abstract

The elimination of amobarbital in dogs was investigated by injecting various doses of amobarbital into a given animal. At low doses (3 mg/kg) serum levels declined in a first-order fashion. Superficially, at high doses (20 mg/kg) the relationship between serum concentration and time could be quantitatively characterized by simple one-compartment saturable kinetics. Indeed, qualitatively, saturation of the amobarbital-metabolizing enzymes was indicated by a shallower initial slope of the semilogarithmic concentration--time profile at the high than at the low dose. However, in addition, an acute enzyme induction phenomenon was observed which was indicated by a shorter terminal half-life of amobarbital at the high dose than after the low dose and also by a shortening in antipyrine half-life.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702272     DOI: 10.1007/bf01060094

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  11 in total

1.  Genetic study of amobarbital elimination based on its kinetics in twins.

Authors:  L Endrenyi; T Inaba; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

2.  Ethyl (3-hydroxyisoamyl) barbituric acid as the principal metabolite of amytal.

Authors:  E W MAYNERT
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

3.  The metabolism of amytal labeled with N15 in dogs.

Authors:  E W MAYNERT; H B VAN DYKE
Journal:  J Pharmacol Exp Ther       Date:  1950-02       Impact factor: 4.030

4.  Salivary excretion of amobarbital in man.

Authors:  T Inaba; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

5.  (2-14C) amobarbital metabolism in tolerant rats.

Authors:  A L Misra; R B Pontani; S J Mulé
Journal:  Xenobiotica       Date:  1974-07       Impact factor: 1.908

6.  Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers.

Authors:  S Lindgren; P Collste; B Norlander; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

7.  Implications of enzyme induction in drug toxicity studies.

Authors:  R M Welch; Y E Harrison; J J Burns
Journal:  Toxicol Appl Pharmacol       Date:  1967-03       Impact factor: 4.219

8.  Amobarbital--a probe of hepatic drug oxidation in man.

Authors:  T Inaba; B K Tang; L Endrenyi; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

9.  The kinetics of amylobarbitone metabolism in healthy men and women.

Authors:  K Balasubramaniam; S B Lucas; G E Mawer; P J Simons
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

10.  Metabolism of amylobarbitone in patients with chronic liver disease.

Authors:  G E Mawer; N E Miller; L A Turnberg
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

View more
  1 in total

1.  Fractions metabolized in a triangular metabolic system: cinromide and two metabolites in the rhesus monkey.

Authors:  E A Lane; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1985-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.